CDKN1B and atherosclerosis: Mounting evidence suggested that CDKN1B is a key regulator of cell cycle progression, which was recognized as an important senescence marker in aging-related diseases such as osteoporosis [49, 50], atherosclerosis [51] and Alzheimer’s disease [52].